Sanovi Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 06-07-2024
- Paid Up Capital ₹ 4.60 M
as on 06-07-2024
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.60 Cr
as on 06-07-2024
- Revenue 16.48%
(FY 2023)
- Profit -29.36%
(FY 2023)
- Ebitda -16.60%
(FY 2023)
- Net Worth 133.89%
(FY 2023)
- Total Assets 70.86%
(FY 2023)
About Sanovi Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 4.60 M.
The company currently has active open charges totaling ₹2.60 Cr.
Srinivasa Madasani and Koteswararao Madasani serve as directors at the Company.
- CIN/LLPIN
U74999KA2018PTC115284
- Company No.
115284
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Aug 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sanovi Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivasa Madasani  | Managing Director | 06-Aug-2018 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Koteswararao Madasani | Director | 04-Dec-2019 | Current |
Financial Performance of Sanovi Pharmaceuticals.
Sanovi Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.48% increase. The company also saw a substantial fall in profitability, with a 29.36% decrease in profit. The company's net worth Soared by an impressive increase of 133.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanovi Pharmaceuticals?
In 2023, Sanovi Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 01 Dec 2022 | ₹1.40 Cr | Open |
Others Creation Date: 30 Nov 2021 | ₹1.20 Cr | Open |
How Many Employees Work at Sanovi Pharmaceuticals?
Unlock and access historical data on people associated with Sanovi Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanovi Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanovi Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
